Savant Capital LLC Sells 5,206 Shares of SPDR S&P China ETF (NYSEARCA:GXC)

Savant Capital LLC lowered its stake in SPDR S&P China ETF (NYSEARCA:GXC) by 12.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 36,283 shares of the company’s stock after selling 5,206 shares during the quarter. Savant Capital LLC owned approximately 0.55% of SPDR S&P China ETF worth $2,753,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Optimum Investment Advisors lifted its stake in SPDR S&P China ETF by 11.5% in the third quarter. Optimum Investment Advisors now owns 1,799 shares of the company’s stock valued at $148,000 after acquiring an additional 185 shares during the last quarter. Osborne Partners Capital Management LLC lifted its stake in SPDR S&P China ETF by 3.0% in the 3rd quarter. Osborne Partners Capital Management LLC now owns 192,829 shares of the company’s stock valued at $15,835,000 after purchasing an additional 5,564 shares during the last quarter. GSB Wealth Management LLC acquired a new position in SPDR S&P China ETF during the third quarter worth approximately $75,000. swisspartners Advisors Ltd raised its stake in SPDR S&P China ETF by 1.8% in the third quarter. swisspartners Advisors Ltd now owns 132,307 shares of the company’s stock valued at $10,865,000 after buying an additional 2,360 shares during the period. Finally, Banco Santander S.A. acquired a new stake in shares of SPDR S&P China ETF in the third quarter valued at approximately $3,132,000.

SPDR S&P China ETF Trading Up 2.4 %

GXC stock opened at $82.64 on Thursday. The business’s 50 day simple moving average is $76.75 and its 200 day simple moving average is $75.23. SPDR S&P China ETF has a 1-year low of $61.91 and a 1-year high of $97.17. The firm has a market capitalization of $549.56 million, a PE ratio of 9.52 and a beta of 0.84.

SPDR S&P China ETF Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.